Zealand Pharma A/S Stock

Equities

ZEAL

DK0060257814

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen 11:20:00 2024-06-14 EDT 5-day change 1st Jan Change
662.5 DKK +2.24% Intraday chart for Zealand Pharma A/S +1.92% +77.52%

Financials

Sales 2024 * 441M 63.24M 86.82M Sales 2025 * 1.02B 146M 200M Capitalization 41.27B 5.92B 8.13B
Net income 2024 * -653M -93.68M -129M Net income 2025 * -399M -57.24M -78.58M EV / Sales 2024 * 88.3 x
Net cash position 2024 * 2.37B 340M 466M Net cash position 2025 * 2.44B 350M 480M EV / Sales 2025 * 38.2 x
P/E ratio 2024 *
-66.3 x
P/E ratio 2025 *
-69.8 x
Employees 270
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.32%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.24%
1 week+1.92%
Current month+3.60%
1 month+1.38%
3 months-5.02%
6 months+87.25%
Current year+77.52%
More quotes
1 week
610.00
Extreme 610
676.00
1 month
560.00
Extreme 560
681.00
Current year
342.20
Extreme 342.2
749.00
1 year
212.20
Extreme 212.2
749.00
3 years
69.55
Extreme 69.55
749.00
5 years
69.55
Extreme 69.55
749.00
10 years
58.00
Extreme 58
749.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 09-12-31
Director of Finance/CFO - 22-10-31
Chief Operating Officer 52 18-02-28
Members of the board TitleAgeSince
Director/Board Member 66 19-04-03
Chairman 69 14-12-31
Director/Board Member 68 18-04-18
More insiders
Date Price Change Volume
24-06-14 662.5 +2.24% 393,732
24-06-13 648 +5.97% 486,447
24-06-12 611.5 -5.49% 334,427
24-06-11 647 -1.82% 258,478
24-06-10 659 +1.38% 277,641

Delayed Quote Nasdaq Copenhagen, June 14, 2024 at 11:20 am

More quotes
Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity. At the end of 2022, the Group had a portfolio of 7 products in clinical development (including 2 in phase III, 3 in phase II and 2 in phase I), and 4 products in preclinical development.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
662.5 DKK
Average target price
790.9 DKK
Spread / Average Target
+19.37%
Consensus